Сумамокс

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Сумамокс

Quick Facts

Property Description
Active ingredient Azithromycin (Azithromycin Dihydrate)
Form Tablets, Capsules, Powder for Oral Suspension
Pharmacological class Macrolide Antibiotic (Azalide Subclass)
Common use Treatment of susceptible bacterial infections
Origin Synthetic (derived semi-synthetically from Erythromycin)

What Type of Medicine is Сумамокс?

Сумамокс is a specialized, prescription-only antibacterial drug intended for systemic application, with its activity defined by the core active ingredient, Azithromycin. Azithromycin is chemically classified as a macrolide antibiotic, belonging more specifically to the structurally differentiated azalide subclass. The original formulation often prioritizes the oral suspension and tablet forms, making it suitable for a wide range of patients.

The active substance is a synthetic compound, derived semi-synthetically from Erythromycin, and is recognized in pharmacological studies for its distinctive structure. Сумамокс is always a single-active ingredient product intended to halt the spread of susceptible bacterial infections across a variety of pathogens.

What Forms of Сумамокс are Available?

The medicinal entity is generally available for oral consumption in several standardized dosage forms, including tablets, capsules, and a powder for suspension which is reconstituted to form an oral suspension. These forms are designed for systemic use, ensuring the medication is absorbed into the bloodstream for distribution throughout the body.

The formulation includes the active ingredient, often as Azithromycin Dihydrate, combined with non-active excipients required for stability and delivery. The availability of varied forms, such as the oral suspension, facilitates accurate administration to diverse patient groups, including pediatric patients.

How Does Сумамокс Function at a Basic Level?

The fundamental purpose of Сумамокс is to control and resolve infections by stopping the growth and reproduction of infectious bacteria. This antimicrobial effect is achieved because Azithromycin works by binding to the 50S bacterial ribosomal subunit, thereby inhibiting crucial bacterial protein synthesis. This action classifies it as a broad-spectrum agent whose primary benefit is to neutralize the proliferation of susceptible bacteria, thereby assisting the body's natural defenses in clearing the established infection. This mechanism is crucial in scenarios such as managing an uncomplicated respiratory tract infection, offering a reliable means to combat the bacterial agent responsible.

Regulatory References

  1. Azithromycin - StatPearls - NCBI Bookshelf

What side effects are possible with Сумамокс?

Possible side effects and safety information for Сумамокс

Сумамокс is a trade name for amoxicillin, a penicillin-class antibiotic. Its safety profile is well-documented in regulatory sources, highlighting risks ranging from common gastrointestinal issues to rare, life-threatening allergic reactions.

Commonly Reported Adverse Reactions (Frequency ge 1%):

The most frequent side effects involve the gastrointestinal and dermatological systems, and typically include diarrhea, nausea, vomiting, and skin rash. In children, temporary tooth discoloration (yellow, brown, or gray staining) has been reported.

Serious and Clinically Significant Adverse Reactions:

  • Hypersensitivity: Severe, immediate allergic reactions (anaphylaxis) are a risk and require immediate attention, particularly in patients with a history of penicillin or cephalosporin allergy.
  • Severe Skin Reactions: Rare but serious cutaneous adverse reactions (SCAR), such as Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), have been documented.
  • Gastrointestinal: Severe diarrhea, which may be watery or bloody, may occur during or even months after treatment, potentially indicating Clostridioides difficile-associated diarrhea (CDAD). Rare cases of Drug-Induced Enterocolitis Syndrome (DIES), predominantly in pediatric patients, have been reported.
  • Hepatobiliary and Renal: Rare reports include transient changes in liver enzyme levels, hepatitis, cholestatic jaundice, and signs of kidney problems like interstitial nephritis.
  • Hematologic/Nervous System: Very rarely, changes in blood cell counts (leukopenia, thrombocytopenia) and central nervous system effects such as confusion, dizziness, or convulsions have been noted.

Safety Restrictions and Population Considerations:

This medication is contraindicated in individuals with a known hypersensitivity to penicillin or other beta-lactam antibiotics. Caution is advised for patients with severe kidney disease, as dosage adjustment may be necessary. Use in patients with infectious mononucleosis is generally discouraged due to a high risk of developing a generalized skin rash. Amoxicillin may reduce the effectiveness of hormonal contraceptives, and its use with anticoagulants (e.g., warfarin) requires monitoring due to the potential for prolonged bleeding time.

Overdose and Emergency Response

Overdose Manifestations and Severe Risks

Overdosage of Сумамокс (Azithromycin), as documented in official regulatory labeling, typically presents with adverse reactions similar to those observed at therapeutic doses, chiefly impacting the gastrointestinal system. Documented manifestations include severe nausea, vomiting, and diarrhea. Additionally, the official profile notes the risk of reversible loss of hearing as a possible symptom associated with macrolide antibiotic overdose. Critically, overdosage can elevate the risk of a severe, potentially fatal irregular heart rhythm, specifically Torsades de pointes, linked to QT interval prolongation. Regulatory authorities note that individuals, particularly elderly patients and those with pre-existing cardiac conditions, may be at increased risk of these severe arrhythmogenic effects.

Official Emergency Actions and Management

Regulatory guidance explicitly mandates that any suspected overdosage requires immediate medical attention. Urgent contact with emergency services must be made if severe, life-threatening clinical signs are observed, including collapse, seizure, trouble breathing, or inability to be awakened (unresponsiveness). The official management strategy involves general symptomatic and supportive measures to address the presenting clinical status. The administration of medicinal charcoal may be indicated as part of this supportive care. Regulatory documents state that no specific antidote is known for Azithromycin overdosage.

Therapeutic Uses of Сумамокс

What Сумамокс Treats: Main Uses and Benefits

Сумамокс (Azithromycin) is commonly used for managing a variety of bacterial infections, addressing conditions where symptoms are linked to heightened physiological activity across key systems. It is applied in scenarios where symptoms create noticeable physiological strain, offering supportive treatment during phases of increased distress or discomfort. This medication is indicated for infections of the ears, lungs, sinuses, skin, throat, and reproductive organs.


Therapeutic Scope and Symptom Management

This medication is generally used across conditions presenting with acute episodes of bacterial infection. Its use is considered relevant in addressing respiratory conditions like community-acquired pneumonia, acute bronchitis, pharyngitis, and tonsillitis; ear infections (acute otitis media); skin and skin-structure infections such as cellulitis and impetigo; and certain uncomplicated sexually transmitted infections (STIs).

It contributes to easing associated symptoms related to physical discomfort, such as cough, sputum production, sore throat, and fever. It also assists with managing symptoms related to inflammatory and irritative states, such as localized inflammation and tenderness. This supportive role helps maintain a sense of stability when symptoms are more noticeable.


Quick Fact: Relief for Symptom Burden
This antibiotic is commonly applied in scenarios where acute bacterial infections lead to symptoms that interfere with daily functioning, such as persistent cough, fever, and localized inflammatory discomfort.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

The eligibility to use Сумамокс (Azithromycin) is determined by official regulatory criteria related to allergies, pre-existing conditions, and patient age, as documented in government prescribing information.

Contraindications and Restrictions

Classification Population or Condition Regulatory Status
Contraindicated Hypersensitivity to Azithromycin or any macrolide/ketolide antibiotic. Must not use
Contraindicated History of cholestatic jaundice or hepatic dysfunction from prior Azithromycin use. Must not use
Restricted Use Known QTc prolongation or proarrhythmic conditions (e.g., severe bradycardia). Use with extreme caution
Restricted Use Severe hepatic impairment or severe renal impairment ( GFR < 10 ml/min). Caution/Not recommended

Age and Physiological Eligibility

  • Infants under 6 months: Use is generally not established for most labeled indications.
  • Pediatric Use: Tablets are typically restricted to children weighing over 45 kg; the oral suspension is used for lower weights.
  • Pregnancy/Lactation: Use during pregnancy is permitted only when the clear therapeutic benefit is judged to outweigh the potential risk. Use during lactation is restricted due to excretion into breast milk.

What should I know about interactions with other medicines?

The interaction profile for Сумамокс (Azithromycin) is defined by constraints related to both pharmacokinetic exposure and additive pharmacodynamic effects documented in regulatory labeling.

Formal Restrictions and High-Risk Combinations

The co-administration of Azithromycin and ergot derivatives (such as Ergotamine) is strictly restricted due to the theoretical possibility of ergotism. Azithromycin carries an additive risk for QT interval prolongation when combined with other medicines known to affect cardiac repolarization, including specific Class IA and III antiarrhythmics and agents like Pimozide. This QT risk is noted to be heightened in specific patient populations, particularly elderly patients and women.

Pharmacokinetic and Exposure Alterations

Azithromycin may increase the serum concentration of co-administered drugs that are substrates of the P-glycoprotein (P-gp) efflux transporter, including Digoxin and Colchicine. Conversely, co-administration with the HIV protease inhibitor Nelfinavir results in increased Azithromycin serum concentrations. The oral anticoagulant Warfarin may experience increased coagulation times when combined with Azithromycin.

Administration Timing and Food

To prevent a reduction in Azithromycin's peak plasma concentration, co-administration with Aluminum- or Magnesium-containing Antacids must be separated by an interval of at least 2 hours. Taking Azithromycin with food results in a documented increase in the peak concentration ( Cmax) of both the tablet (23%) and oral suspension (56%) formulations.

Mechanism of Action

Molecular Blockade of Bacterial Protein Synthesis

The primary mechanism of Сумамокс (Azithromycin) is achieved by binding to the 23S ribosomal RNA (rRNA) component of the microbial 50S ribosomal subunit. This drug-target interaction physically obstructs the ribosome's exit tunnel, functionally acting as a specific inhibitor of protein translation. This action halts the assembly of all essential bacterial proteins, enzymes, and structural components, which are required for cellular growth and replication.

Arresting Cellular Proliferation (Bacteriostasis)

The suppression of protein synthesis leads to a crucial physiological consequence: the arrest of microbial cellular proliferation (a bacteriostatic effect). Leading to the cessation of bacterial growth and replication, this action contributes to a non-proliferating state in the microbial population, resulting in a functional decrease of viable pathogens. This key mechanistic step facilitates the clearance of non-proliferating organisms by the host immune response, which characterizes the primary biological consequence of this mechanism.

️ Limitations via Bacterial Resistance Pathways

The mechanistic activity of the drug can be constrained by specific bacterial defense systems. Resistance often arises when bacteria acquire genes that either code for efflux pumps (which actively expel the drug before it reaches the 50S subunit) or produce enzymes that methylate the ribosomal target site. These pathways directly reduce the drug's binding affinity or concentration, circumventing the intended molecular blockade.

Dosage and Administration Information

How to Use Сумамокс

Сумамокс (Azithromycin) is intended for systemic treatment and is administered via the oral and intravenous (IV) routes. The oral route is used for most approved regimens, while the IV route is reserved for patients requiring initial, supervised therapy in settings like community-acquired pneumonia.

Dosing Regimens and Frequency

Administration typically follows a once-daily pattern due to the drug's long half-life. Standard adult dosing generally involves two main courses:

  • Five-Day Regimen (Sequential Dosing): 500 mg is taken on Day 1, followed by 250 mg once daily on Days 2 through 5.
  • Three-Day Regimen (Short Course): 500 mg is taken once daily for three consecutive days.

For specific uncomplicated infections, the regimen may be a single oral dose of 1 gram (1000 mg).

Administration Conditions and Adjustments

Most oral forms (tablets and standard suspension) can be administered with or without food. However, certain specialized, single-dose oral suspensions are recommended to be taken on an empty stomach (at least one hour before or two hours after a meal).

For the pediatric population, dosing for children is determined based on the child's body weight (mg/kg) using the oral suspension form. No routine dose adjustment is required for adults with mild to moderate renal or hepatic impairment. The intravenous formulation must be reconstituted and diluted prior to administration and infused over a period of 1–3 hours.

Recent Clinical Evidence

Research Evidence / Overview of Studies

The Molecule: Research into its Mechanism of Action

The molecule is a novel anti-inflammatory agent for which studies have evaluated its potential role in chronic tendon pain, such as Achilles tendinopathy and lateral epicondylitis.

Research has investigated the molecule’s properties, and its high selectivity for the COX-2 enzyme was the focus of studies examining its tolerability profile.


Clinical Efficacy Studies in Tendinopathy

Multiple controlled studies have examined the research subject in adults experiencing chronic tendon pain.

  • Pain and Function Outcomes: Clinical studies evaluated the molecule’s effect on pain intensity and function, noting data collection points that extended for up to six months.
  • Administration and Absorption: Studies noted that the drug was administered with a meal to evaluate absorption. Research findings did not evaluate absorption or efficacy when the molecule was administered without food.
  • Combination Therapy: Studies assessed whether the combination therapy affected recovery time compared to physical therapy alone.

Tolerability and Safety Profile

The clinical research evaluated the molecule’s safety profile across various patient populations and treatment durations.

  • Gastrointestinal Tolerability: Studies have explored the molecule's tolerability profile in various populations, including individuals with gastrointestinal concerns. The data collected was compared to subjects who received placebo.
  • Cardiovascular Safety: Long-term follow-up studies examined the cardiovascular safety of the molecule over 12 months.
  • Acute Flare Research: Research is ongoing to determine the molecule’s effect in patients experiencing acute flares.

The full results and detailed discussion of these trials are available in the public domain and regulatory filings.

Frequently Asked Questions (FAQ)

Common questions about Сумамокс (FAQ)


Q: Is Сумамокс the same as Amoxicillin?

No, Сумамокс, which contains the active ingredient Azithromycin, is chemically classified as a macrolide antibiotic. Amoxicillin, by contrast, is a penicillin-type antibiotic. Official documents indicate they belong to distinct pharmacological classes with different mechanisms for stopping bacterial growth.

Q: Is Сумамокс a type of penicillin?

No, the active ingredient in Сумамокс is Azithromycin, which is chemically classified as a macrolide antibiotic. Macrolides operate through a different mechanism than penicillin-class drugs, which is why official sources list them separately.

Q: What is Сумамокс used for?

Official documents state that this drug is indicated for the treatment of mild to moderate infections caused by specific, susceptible bacteria. This generally includes certain infections affecting the respiratory tract, skin, and areas related to sexually transmitted diseases.

Q: What kind of infections does Сумамокс treat?

Regulatory documents indicate use for a range of bacterial infections. This includes acute bacterial sinusitis, community-acquired pneumonia, pharyngitis/tonsillitis, and urethritis/cervicitis when caused by susceptible organisms.

Q: Is Сумамокс used for skin infections?

Yes, the official indications include the treatment of uncomplicated skin and skin structure infections when caused by designated susceptible bacteria. This is one of the various types of infections listed in the product's regulatory filing.

Q: Is Сумамокс effective against viral infections?

No, official sources indicate these drugs are not effective against viral illnesses like the common cold or influenza (flu). Antibiotics such as Azithromycin are designed only to neutralize susceptible bacterial infections.

Q: How quickly does Сумамокс start working?

The active substance, Azithromycin, is rapidly absorbed after being taken orally. Due to its long half-life, the drug quickly moves from the blood into the body's tissues, where the active ingredient is released over a prolonged period to exert its antimicrobial effect.

Q: How long does the effect of Сумамокс last in the body?

Studies show that Azithromycin has a mean terminal elimination half-life of 68 hours. This means the drug stays in the body's tissues for a prolonged period, which is why it is commonly prescribed for once-daily or short-course regimens.

Q: Are headaches a common side effect of Сумамокс?

Yes, regulatory-cited data indicates that headaches are listed among the commonly reported side effects of Azithromycin. Regulatory information describes the possible side effects, but does not provide guidance on self-management.

Q: Is it common to feel tired while taking Сумамокс?

Fatigue is listed among the commonly reported side effects according to official drug safety information. Patients may also experience a feeling of tiredness or dizziness while using this medication.

Q: Is a metallic taste in the mouth possible with Сумамокс?

Yes, changes to your sense of taste are documented as possible side effects. This can include a metallic, bitter, or sour taste in the mouth, or even a temporary loss of taste.

Q: What should I do if I forget to take Сумамокс?

Official patient information outlines the recommended course of action for a missed dose, which typically involves instructions based on the time elapsed since the missed dose. This guidance should be reviewed on the prescription leaflet.

Q: What if I vomit shortly after taking Сумамокс?

The official patient information provides guidance for scenarios where absorption may be compromised, such as vomiting. It details the conditions under which a healthcare provider should be consulted if vomiting occurs shortly after administration.

Q: Can I stop taking Сумамокс if I feel better?

Official guidance emphasizes that the prescribed course is intended to be completed to fully address the underlying infection, even if symptom improvement occurs early. This practice is cited as necessary to avoid incomplete bacterial elimination.

Q: Is Сумамокс approved for use during pregnancy?

Official documents contain conditional statements on use during pregnancy, indicating it is permitted only when the therapeutic benefit is judged to outweigh the potential risk. The prescribing decision is based on a professional assessment of these factors.

Q: What are the official guidelines for using Сумамокс while breastfeeding?

Official guidance notes that the drug passes into breast milk and recommends being aware of possible infant gastrointestinal effects, such as vomiting, diarrhea, or rash. The use during lactation is restricted based on these factors.

Q: Can older adults use Сумамокс safely?

While the drug is generally processed similarly in older adults, official warnings note that people over 60 years old can be at greater risk for certain serious side effects. This includes heart rhythm changes, specifically QT prolongation.

Q: Does Сумамокс contain sulfa?

No. The active ingredient in Сумамокс is Azithromycin, a macrolide antibiotic. This chemical structure does not contain sulfonamide (sulfa) components, which are found in sulfa-based drugs.

Q: How is Сумамокс known to affect gut flora?

Like other antibiotics, this drug can disrupt the normal balance of microorganisms in the gut. This change can sometimes allow an overgrowth of Clostridioides difficile, which can lead to a serious condition known as C. difficile-associated diarrhea (CDAD).

Q: What should be monitored while taking Сумамокс according to official documents?

Official product information notes that monitoring may be indicated for patients taking the drug with certain medications, such as warfarin, or those with specific risk factors like QTc prolongation and signs of liver damage (hepatic impairment).

Q: Is it safe to drink coffee while on Сумамокс?

Official regulatory documents provide limited specific information on the interaction with caffeine. In general, consuming moderate amounts of caffeine from beverages like coffee or tea is not listed as a contraindication.

Q: What happens if I take Сумамокс with alcohol?

Official sources do not typically indicate that alcohol reduces the drug's effectiveness. However, consuming alcohol can potentially intensify common side effects like headache, nausea, and stomach pain, and may place extra stress on the liver.

Q: Can I take Сумамокс if I am also taking vitamins?

Regulatory guidelines specify that all concomitant therapies, including vitamins, minerals, herbal products, and other supplements, should be noted in the patient's record for review.

Q: Does Сумамокс interact with supplements like St. John's Wort?

Official guidelines specify that the use of herbal products and supplements, such as St. John's Wort, should be disclosed as part of the medication history review.

Q: What is the official safety classification for Сумамокс?

The drug is officially designated as a prescription-only macrolide antibacterial drug. Regulatory documents also specify its classification for use with caution in specific patient populations, particularly those with risk factors for QTc prolongation (heart rhythm changes).

Q: What does the patient information leaflet say about overdose for Сумамокс?

The official product information states that the expected symptoms of an overdose are generally consistent with common adverse reactions, primarily severe nausea, vomiting, and diarrhea. Reversible hearing loss has also been reported in cases of high doses.

Q: Is there a maximum time someone can take Сумамокс?

Official regulatory documents specify treatment regimens that typically range from 1 to 5 days for most approved indications. The maximum duration of therapy is strictly dictated by the specific approved regimen for the condition being treated.

Q: How long does it take for Сумамокс to clear up an infection?

While treatment regimens are typically short, lasting 3 to 5 days, the actual time required for clinical resolution (symptom improvement) depends on the specific infection being treated and the patient's individual immune response.

Q: What is the difference between Сумамокс and the generic version?

The generic version contains the same active ingredient, Azithromycin, in the same dosage form and strength. Both are approved by regulatory bodies, and the primary difference is usually the name and the non-active ingredients (excipients) used in the formulation.

Q: Where can I find the official regulatory information about Сумамокс?

Official information can be found on the government-run public databases of regulatory agencies. Key sources include the FDA DailyMed/Drugs@FDA database in the United States and the EMA SmPC (Summary of Product Characteristics) database in the European Union.

Q: What countries have approved the use of Сумамокс?

The active ingredient, Azithromycin, is approved for medical use by major regulatory bodies worldwide. These include the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), Health Canada, and others.

How should Сумамокс be stored and disposed of?

How to Store and Dispose of Сумамокс (Azithromycin)

Official regulatory guidelines dictate specific storage and disposal requirements to maintain the stability and safety of Azithromycin.

Storage Conditions

Formulation Required Conditions
Tablets/Capsules & Dry Powder Store at controlled room temperature (20 C to 25 C), protected from excessive heat and moisture.
Reconstituted Oral Suspension Must be refrigerated (5 C or below). Do not freeze.

The medication must be kept in its tightly closed, original container and stored out of the sight and reach of children.

Stability and Disposal

The reconstituted liquid suspension has a 10-day stability period and must be discarded after 10 days.

Unused or expired Azithromycin must not be disposed of via wastewater or household waste. Disposal must comply with local requirements for pharmaceutical waste, such as official drug take-back programs.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Сумамокс found in:

A-Z Index: